Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer

Recruiting

Phase 1

Phase 2

CaphosolCaphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer

Sponsor:

Jazz Pharmaceuticals

Code:

NCT00901732

Conditions

Oral Mucositis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Caphosol

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-16. This information was provided to ClinicalTrials.gov by Jazz Pharmaceuticals on 2009-05-14.